Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Infection and Hematologic Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04666025
What this trial is testing

SARS-CoV-2 Donor-Recipient Immunity Transfer

Who this might be right for
Accelerated Phase CML, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+10 more
City of Hope Medical Center 26
Not applicableStudy completedNCT06900114
What this trial is testing

Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China

Who this might be right for
MucormycosisHematologic MalignanciesCOVID-19
Institute of Hematology & Blood Diseases Hospital, China 60
Not applicableStudy completedNCT05721066
What this trial is testing

Hemostatic Profile of Post COVID-19/Long COVID-19 Patients

Who this might be right for
COVID-19Post-acute COVID-19 Syndrome
IRCCS Policlinico S. Donato 102
Not applicableUnknownNCT05206903
What this trial is testing

Emotional and Physical Health Status of Adults

Who this might be right for
Pandemic, COVID-19Adult ALL
Pamukkale University 250
Early research (Phase 1)Active Not RecruitingNCT07709637
What this trial is testing

Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients

Who this might be right for
COVID-19COVID-19 (SARS-CoV-2 Infection)
LucasBio 1
Not applicableStudy completedNCT05126602
What this trial is testing

Vitamin D Supplementation and Clinical Improvement in COVID-19

Who this might be right for
COVID-19
Bumi Herman 60
Not applicableActive Not RecruitingNCT07204366
What this trial is testing

Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)

Who this might be right for
Myeloproliferative DiseaseCOVID - 19
Fondazione IRCCS Policlinico San Matteo di Pavia 219
Testing effectiveness (Phase 2)Ended earlyNCT04426201
What this trial is testing

InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O )

Who this might be right for
COVID-19Lymphocytopenia
Revimmune 10
Testing effectiveness (Phase 2)WithdrawnNCT05040776
What this trial is testing

COVID-19 ThromboprophylaXIs Study of Novel FXIa Inhibitor Frunexian (EP-7041) in ICU Patients

Who this might be right for
ThrombopeniaCovid19
eXIthera Pharmaceuticals
Not applicableUnknownNCT04366154
What this trial is testing

Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers

Who this might be right for
COVID-19Cancer
Centre Francois Baclesse 809
Not applicableStudy completedNCT04422470
What this trial is testing

Registry of Patients With Hematologic Disease and COVID-19 in Russia

Who this might be right for
Coronavirus Infection and Hematologic Diseases
National Research Center for Hematology, Russia 666
Not applicableLooking for participantsNCT05022446
What this trial is testing

The Impact of COVID-19 on Pulmonary Procedures

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 250
Not applicableStudy completedNCT04487119
What this trial is testing

Hematology and Clinical Picture in Pediatric COVID-19 Infection

Who this might be right for
Covid19
Benha University 29
Not applicableStudy completedNCT05422937
What this trial is testing

Symptom Patterns and Life With Longer Term COVID-19 in Children and Young People (SPLaT-19 Cohort & Qualitative Study)

Who this might be right for
COVID-19Pediatric ALL
Keele University 502
Testing effectiveness (Phase 2)Active Not RecruitingNCT04977024
What this trial is testing

SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid System NeoplasmLeukemia+2 more
GeoVax, Inc. 63
Not applicableStudy completedNCT04356950
What this trial is testing

Analysis of the Coagulopathy Developed by COVID-19 Infected Patients

Who this might be right for
SepsisBlood Coagulation DisordersThrombin+2 more
Centre Hospitalier Universitaire de Nīmes 175
Testing effectiveness (Phase 2)Ended earlyNCT04442178
What this trial is testing

InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I )

Who this might be right for
COVID-19Lymphocytopenia
Revimmune 26
Not applicableStudy completedNCT05675943
What this trial is testing

Efficacy and Safety of the Anti-COVID-19 Antibody SA55 for Injection in Patients With Hematological Disorders Who Are Persistently Positive for COVID-19

Who this might be right for
Hematological DisordersCOVID-19
Beijing Boren Hospital 31
Testing effectiveness (Phase 2)WithdrawnNCT04392128
What this trial is testing

Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)

Who this might be right for
COVID19Hematologic Malignancy
Institut de cancérologie Strasbourg Europe
Not applicableLooking for participantsNCT04278404
What this trial is testing

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Who this might be right for
Coronavirus Infection (COVID-19)Pulmonary Arterial HypertensionUrinary Tract Infections in Children+22 more
Duke University 5,000
Next Page